home-campaign

Lincoln Wilson

lincoln-wilson

Lincoln Wilson

Lincoln Wilson focuses his practice on complex product liability, mass torts, and class action litigation, with an emphasis on appellate litigation and issues of jurisdiction and procedure. He has significant experience representing clients in large-scale multi-district matters in federal, state, and tribal courts around the country at both the trial and appellate level. 

Mr. Wilson advises petrochemical, pharmaceutical, plastics manufacturing, telecommunications, tobacco, and transportation companies in relation to matters including product liability, class actions, RICO, False Claims Act, and insurance litigation. Mr. Wilson has experience handling all aspects of complex litigation, including strategy for jurisdictional and dispositive motions, taking and defending fact and expert depositions, motion practice on Daubert and class certification, evidentiary hearings and trial, interlocutory and final judgment appeals, and mass resolution strategy. He has practiced in the U.S. Supreme Court and eight federal courts of appeals and is a volunteer with the Ninth Circuit’s pro bono program. In 2020, he received Dechert’s “Exceptional Teacher” award.

Mr. Wilson’s writing on life sciences litigation has appeared in Law360. Prior to joining Dechert, he was a litigation associate in Quinn Emanuel Urquhart & Sullivan’s Seattle office.

Experience
Complex Business Litigation
  • Pfizer Inc. in a multi-plaintiff products liability action in the Southern District of New York alleging type 2 diabetes from the prescription medication Lipitor. Mr. Wilson briefed and argued Pfizer’s motion to dismiss on the grounds of FDCA preemption post Merck Sharpe & Dohme v. Albrecht, which the court granted in its entirety.
  • Pfizer Inc. in a multi-district transferee court and on appeal to the Fourth Circuit from a multi-district litigation alleging personal injuries from the prescription medication Lipitor. The Fourth Circuit affirmed in every respect the district court’s grant of summary judgment as to the entire litigation consisting of more than 3,000 claims due to lack of admissible expert testimony on causation.
  • Endo International plc and affiliates in a multi-district transferee court and on appeal to the Sixth Circuit from a multi-district litigation alleging personal injuries from prescription medications containing propoxyphene. The Sixth Circuit affirmed in all respects the district court’s dismissal of all claims against Endo as pre-empted by federal law.
  • Endo International plc and affiliates in an appeal to the Ninth Circuit concerning subject matter jurisdiction. The Ninth Circuit ultimately issued an en banc decision affirming the theory of jurisdiction under the Class Action Fairness Act advanced by Endo and co-defendants.
  • A large medical device manufacturer in complex litigation defending against veil-piercing and alter ego theories of personal jurisdiction over international parent company including three-day evidentiary hearing.
  • A large manufacturer in several federal district courts and on appeal to the First and Second Circuit in ongoing environmental class action litigation seeking medical monitoring and purported property damage due to alleged contamination of groundwater.
  • A national retail pharmacy chain in proceedings in tribal court and federal district court concerning a novel action by the tribe relating to abuse of prescription opioid medications. The federal court granted a preliminary injunction in favor of the pharmacy chain and co-defendants restraining enforcement of the tribal court action.
  • Hungarian telecommunications companies in federal district court and Fourth Circuit in successful defense against an attempt to enforce a ten-year-old default judgment against non-party foreign respondents. 
  • Pfizer Inc.  in Supreme Court of the United States in complex appellate proceedings concerning subject matter jurisdiction and personal jurisdiction arising out of matters in California state and federal appellate courts.
  • Amgen Inc. in a multi-district transferee court and on appeal to the Ninth Circuit in a RICO litigation by third-party payors alleging overpayment for prescription medications. The Ninth Circuit affirmed the dismissal of the entire litigation on the pleadings.
Pro Bono Representations
  • Amicus curiae briefs in the U.S. Supreme Court and courts of appeals on criminal justice, religious freedom, and class certification matters. 
  • Asylum denial appeal for Tibetan refugee in which Board of Immigration Appeals reversed denial and asylum was granted on remand. 
  • Successful dram shop act litigation against catering hall for overserving patrons convicted for hate-crime assault Sikh man.
  • Landlord-tenant matters for commercial tenants defending against eviction after fire deprived them of heat or hot water for six months. 
Includes matters handled prior to joining Dechert. 
Education
  • University of Idaho, B.Mus., 2004, magna cum laude
  • Seton Hall University School of Law, J.D., 2008, magna cum laude, Order of the Coif, Executive Editor of the Seton Hall Law Review
Admissions
  • New York
  • New Jersey
  • Washington
  • Supreme Court of the United States
  • United States Court of Appeals for the Second Circuit
  • United States Court of Appeals for the Third Circuit
  • United States Court of Appeals for the Fourth Circuit
  • United States Court of Appeals for the Fifth Circuit
  • United States Court of Appeals for the Sixth Circuit
  • United States Court of Appeals for the Eighth Circuit
  • United States Court of Appeals for the Ninth Circuit
  • United States Court of Appeals for the Tenth Circuit
  • United States District Court for the Northern District of New York
  • United States District Court for the Southern District of New York
  • United States District Court for the District of Colorado
  • United States District Court for the District of New Jersey